Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Orefici

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Infection and Immunity|April 1, 1993
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci)C von Hunolstein, S D'Ascenzi, B Wagner, et al.
Infection and Immunity|October 26, 1999
Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional roleA Corti, L Fattorini, O F Thoresen, et al.
Journal of Chemotherapy (Florence, Italy)|March 10, 2001
Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytesS P Prete, A Giuliani, E Iona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell responseE Giacomini, E Iona, L Ferroni, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compoundsM Galleni, N Franceschini, B Quinting, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium aviumL Fattorini, B Li, C Piersimoni, et al.
Infection and Immunity|September 1, 1990
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritisL Tissi, P Marconi, P Mosci, et al.
The European Respiratory Journal|February 7, 2003
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000G B Migliori, R Centis, L Fattorini, et al.
FEMS Immunology and Medical Microbiology|August 1, 1994
Antibody-independent protection in mice against type Ia group B streptococcus lethal infectionL Scaringi, L Tissi, P Cornacchione, et al.
The International Journal of Artificial Organs|May 18, 2006
Virulence factors in enterococcal infections of orthopedic devicesL Baldassarri, R Creti, S Recchia, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Infection and Immunity|April 1, 1993
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci)C von Hunolstein, S D'Ascenzi, B Wagner, et al.
Infection and Immunity|October 26, 1999
Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional roleA Corti, L Fattorini, O F Thoresen, et al.
Journal of Chemotherapy (Florence, Italy)|March 10, 2001
Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytesS P Prete, A Giuliani, E Iona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell responseE Giacomini, E Iona, L Ferroni, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compoundsM Galleni, N Franceschini, B Quinting, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium aviumL Fattorini, B Li, C Piersimoni, et al.
Infection and Immunity|September 1, 1990
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritisL Tissi, P Marconi, P Mosci, et al.
The European Respiratory Journal|February 7, 2003
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000G B Migliori, R Centis, L Fattorini, et al.
FEMS Immunology and Medical Microbiology|August 1, 1994
Antibody-independent protection in mice against type Ia group B streptococcus lethal infectionL Scaringi, L Tissi, P Cornacchione, et al.
The International Journal of Artificial Organs|May 18, 2006
Virulence factors in enterococcal infections of orthopedic devicesL Baldassarri, R Creti, S Recchia, et al.
Pageof 9